楼主: sunshine880607
1262 2

求Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practi [推广有奖]

已卖:5270份资源

学科带头人

15%

还不是VIP/贵宾

-

威望
0
论坛币
24396 个
通用积分
25.3209
学术水平
31 点
热心指数
49 点
信用等级
21 点
经验
1785 点
帖子
1043
精华
0
在线时间
2579 小时
注册时间
2009-9-12
最后登录
2026-1-15

楼主
sunshine880607 发表于 2017-2-5 12:29:00 |AI写论文
1论坛币
55555555555555.jpg
Craig H. Mallinckrodt  (2013)
Preventing and Treating Missing Data in Longitudinal Clinical Trials: A Practical Guide

                                                                         媒体推荐                                                              '… this monograph is good value, and I recommend all those involved in the design, conduct or analysis of trials to peruse a copy. Non-statisticians will inevitably be frustrated at times, but if this monograph fosters improved discussion and understanding of the issues raised by missing data in study teams - and how they might be addressed - it will have done its work. In his choice of audience Mallinckrodt set himself a high bar … it has … been cleared. In addition, [his] wry turn of phrase was an unexpected pleasure. You'll miss this if you don't buy it!' James R. Carpenter, Journal of Biopharmaceutical Statistics                                                              
                        
                                                                         作者简介                                                              Craig H. Mallinckrodt is Research Fellow in the Decision Sciences and Strategy Group at Eli Lilly and Company. Dr Mallinckrodt has supported drug development in all four clinical phases and in several therapeutic areas. He currently leads Lilly's Advanced Analytics hub for missing data and their Placebo Response Task Force, and is a member of a number of other scientific work groups. He has authored more than 170 papers, book chapters and texts, including extensive works on missing data and longitudinal data analysis in journals such as Statistics in Medicine, Pharmaceutical Statistics, the Journal of Biopharmaceutical Statistics, the Journal of Psychiatric Research, the Archives of General Psychiatry, and Nature. He currently chairs the Drug Information Association's Scientific Working Group on Missing Data.                                                              
                        
                                                                         目录                                                              Part I. Background and Setting: 1. Why missing data matter; 2. Missing data mechanisms; 3. Estimands; Part II. Preventing Missing Data: 4. Trial design considerations; 5. Trial conduct considerations; Part III. Analytic Considerations: 6. Methods of estimation; 7. Models and modeling considerations; 8. Methods of dealing with missing data; Part IV. Analyses and the Analytic Road Map: 9. Analyses of incomplete data; 10. MNAR analyses; 11. Choosing primary estimands and analyses; 12. The analytic road map; 13. Analyzing incomplete categorical data; 14. Example; 15. Putting principles into practice.                                                              
                        
                                    



关键词:recommend involved conduct design issues
既然没有得到的快乐,又何来失去的痛苦!

沙发
yisherry 发表于 2017-5-4 00:22:11
is this a good book?

藤椅
threeredflag 发表于 2017-5-30 05:40:34
3x3x3x

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
加好友,备注jr
拉您进交流群
GMT+8, 2026-1-17 08:14